Chevron (CVX) Q3 2026 Financial Results Summary
QuoteReporter
Chemron (CVX) Q3 2026: Earnings Surge, Strong Operational Performance — Positive Outlook
Chemron Corporation (NYSE: CVX) reported a robust third quarter for 2026, with earnings reaching $9.9 billion, translating to $5.06 per share (diluted). This marks a significant increase compared to the $3.5 billion or $1.82 per share reported in the same quarter last year, representing a growth of $6.4 billion or 182% YoY. Adjusted earnings were even higher at $10.4 billion or $5.28 per share (diluted).
This quarter's performance is undoubtedly a positive outcome for shareholders, driven by strong operational metrics and strategic investments. The substantial increase in earnings reflects Chemron's ability to capitalize on favorable market conditions, particularly in crude oil and refined product sales.
Key Financial Metrics:
- Reported Earnings: $9.9 billion (up from $3.5 billion YoY)
- Earnings Per Share (EPS): $5.06 (up from $1.82 YoY)
- Adjusted Earnings: $10.4 billion ($5.28 per share)
- Return on Capital Employed: 18%
- U.S. Production: Up 27% from two years ago
- Crude Utilization at U.S. Refineries: 98%
- Quarterly Dividend: $1.78 per share, payable December 10, 2026
Operational Highlights:
- Chemron's U.S. upstream production exceeded 2 million barrels of oil equivalent per day for the fifth consecutive quarter.
- The company achieved record crude throughput at its U.S. refineries, with crude unit throughput reaching 1.09 million barrels per day.
- Chemron's strategic investments include a $7 billion commitment over the next five years to enhance production in Venezuela and reduce midstream costs in the Bakken region by approximately 50%.
Balance Sheet Strength:
Chemron's financial health continues to improve, with total debt reduced by $3.5 billion in the quarter, bringing net debt down by $7.8 billion. The company's total debt now stands at $33.5 billion, with a debt ratio of 14.7%, down from 17.9% at the end of 2025. This reduction in debt enhances Chemron's balance sheet and positions the company favorably for future investments.
Market Outlook:
Looking ahead, investors should monitor Chemron's ongoing efforts to expand its production capabilities, particularly in Venezuela and the Bakken region. The company's focus on operational efficiency and strategic investments is expected to drive further growth. Additionally, the upcoming quarterly dividend payment of $1.78 per share reflects Chemron's commitment to returning value to shareholders.
In summary, Chemron's third quarter results demonstrate a strong operational performance and a commitment to growth, making it a favorable time for shareholders. The company's proactive strategies in expanding production and reducing debt position it well for continued success in the energy sector. Investors should keep an eye on Chemron's developments in the coming quarters, particularly regarding its international operations and capital allocation strategies.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Millions of Dollars, Except Per-Share Amounts)
| 3 Months Ended Sep 30, 2026 | 3 Months Ended Sep 30, 2025 | 9 Months Ended Sep 30, 2026 | 9 Months Ended Sep 30, 2025 | |
|---|---|---|---|---|
| Sales and other operating revenues | $ 65,203 | $ 48,184 | $ 179,229 | $ 138,071 |
| Income (loss) from equity affiliates | $ 2,029 | $ 981 | $ 4,903 | $ 2,390 |
| Other income (loss) | $ 464 | $ 576 | $ 1,530 | $ 1,135 |
| Total revenues and other income | $ 67,696 | $ 49,741 | $ 186,662 | $ 141,596 |
| Cost of revenues | $ 36,195 | $ 27,046 | $ 101,091 | $ 82,173 |
| Selling, general and administrative expenses | $ 9,483 | $ 9,149 | $ 27,346 | $ 24,064 |
| Exploration expenses | $ 259 | $ 288 | $ 720 | $ 727 |
| Depletion, depreciation and amortization | $ 6,263 | $ 5,739 | $ 18,734 | $ 14,712 |
| Taxes other than income taxes | $ 1,307 | $ 1,234 | $ 3,961 | $ 3,932 |
| Income tax expense (benefit) | $ 3,569 | $ 1,843 | $ 9,714 | $ 5,506 |
| Net income (loss) | $ 10,882 | $ 3,658 | $ 24,059 | $ 9,570 |
| Net income (loss) attributable to Chemron Corporation | $ 9,903 | $ 3,540 | $ 24,063 | $ 9,511 |
| Net income (loss) per share of common stock - diluted | $ 5.07 | $ 1.83 | $ 12.31 | $ 5.29 |
| Weighted-average shares used to compute net income per share, diluted | 1,948 | 1,939 | 1,947 | 1,798 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Millions of Dollars)
| September 30, 2026 | December 31, 2025 | |
|---|---|---|
| Cash and cash equivalents | $ 12,804 | $ 6,293 |
| Time deposits | $ 0 | $ 4 |
| Total assets | $ 333,786 | $ 324,012 |
| Total debt | $ 33,534 | $ 40,758 |
| Total Chemron Corporation stockholders' equity | $ 194,327 | $ 186,450 |
| Noncontrolling interests | $ 5,650 | $ 5,726 |
| Total debt plus total stockholders' equity | $ 227,861 | $ 227,208 |
| Debt ratio (Total debt / Total debt plus stockholders' equity) | 14.7 % | 17.9 % |
| Net debt (Total debt less cash and cash equivalents, time deposits and marketable securities) | $ 20,730 | $ 34,461 |
| Net debt plus total stockholders' equity | $ 215,057 | $ 220,911 |
| Net debt ratio (Net debt / Net debt plus total stockholders' equity) | 9.6 % | 15.6 % |
| Cash flow from operations (CFFO)(1) | $ 51,950 | $ 33,939 |
| Debt-to-CFFO ratio (1) | 0.6x | 1.2x |
| Net debt-to-CFFO ratio (1) | 0.4x | 1.0x |
Disclaimer
The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.
